Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In a mouse model of osteoporosis, treatment with MOTS-c improved bone density and microarchitecture, implying that it helped reverse bone loss or accelerate bone regeneration
Factors That Affect Results Response speed and depth vary widely
Sermorelin was previously FDA-approved (as Geref) for diagnosing growth hormone deficiency but was discontinued by its manufacturer for commercial reasons, not safety concerns
Jones SA, Rojas-Caro S, Quinn AG, Friedman M, Marulkar S, Ezgu F, Zaki O, Gargus JJ, Hughes J, Plantaz D, Vara R, Eckert S, Arnoux JB, Brassier A, Le Quan Sang KH, Valayannopoulos V
US$ 29.31
US$ 27.43
US$ 26.77
US$ 25.75
US$ 24.16
US$ 20.89
